Teva Pharmaceutical Industries has an EPS of $-0.5. In 2022, the company made an earnings per share (EPS) of $-2.2. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.5 | -77.27% |
2022 | -$2.20 | -678.95% |
2021 | $0.38 | -110.44% |
2020 | -$3.64 | - |